Modulari-T is a preclinical-stage biotechnology focused on developing synthetic immune receptors and in vivo genetic delivery vectors for multiple immune cell types to achieve better efficacy, safety, and economic feasibility. Their protein design engine has allowed them to rapidly develop a diversified pipeline of modular actuation receptor complex (MARC) T and NK cell therapies delivered in vivo using Modular Vectors (MoVes) for solid tumours, fibrosis, and immune mediated disorders.